Case report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse

4Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

The ongoing transmission of leprosy in India is worrisome, and emerging drug resistance may be one of the factors responsible for the continued transmission of leprosy in India. Emerging cases of multidrug-resistant Mycobacterium leprae pose a great threat to eradication of leprosy and must be addressed with utmost priority. We report a case of multidrug-resistant M. leprae in a case of relapse where slit skin smear (SSS) was negative and histopathology was inconclusive. Drug resistance studies in leprosy are undertaken only in smear-positive relapse cases, and detection of this type of multidrug resistance in a case with negative SSS and innocuous histopathology is rather unusual and highlights the importance of undertaking drug resistance tests even in smear-negative cases of leprosy relapse. Resistance to ofloxacin (OFL) is also a cause for concern as OFL is one of the reserve drugs recommended for treatment of rifampicin-resistant strains.

Cite

CITATION STYLE

APA

Kamat, D., Narang, T., Ahuja, M., Lavania, M., & Dogra, S. (2020). Case report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse. American Journal of Tropical Medicine and Hygiene, 102(4), 724–727. https://doi.org/10.4269/ajtmh.19-0905

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free